Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

Inclusion Criteria: * Healthy adults 20-45 years of age * Weight of ≥ 60kg ≤ 90kg with BMI of ≥ 19 and \< 27 (BMI(kg/m2)= weight(kg)/{height(m)}2 * Voluntary written informed consent Exclusion Criteria: * History or presence of significant renal, neurologic, pulmonary, endocrine, hematology, oncology, urologic, cardiovascular, musculoskeletal or psychiatric disease * Drug allergies to Voriconazole * Recent history or evidence of drug abuse * Recent participation(within 2 months) in other clinical studies * Recent donation of blood(within 2months), plasma(within 1month) or transfusion(within 1month)